Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1635 |
---|---|
Product Name | Anti-SARS-CoV-2 RBD Recombinant Antibody(Etesevimab(JS016)) |
Molecular Name | Etesevimab(JS016) |
Alias | Anti-RBD Recombinant Antibody, Research Grade Etesevimab(JS016) |
Target | RBD[SARS-CoV-2] |
Isotype | Human IgG |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Bamlanivimab/etesevimab is a combination of two monoclonal antibodies, bamlanivimab and etesevimab, administered together via intravenous infusion as a treatment for COVID-19. Both types of antibody target the surface spike protein of SARS‑CoV‑2. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |